AWM
NVO

Aberdeen Wealth Management’s Novo Nordisk NVO Stock Holding History

Aberdeen Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$237K Buy
+4,946
New +$213K 0.11% 112
2025
Q2 		– Sell
-10,040
Closed -$697K – 166
2025
Q1 		$697K Buy
10,040
+60
+0.6% +$4.96K 0.48% 64
2024
Q4 		$858K Hold
9,980
– – 0.59% 43
2024
Q3 		$1.19M Sell
9,980
-850
-8% -$113K 0.78% 34
2024
Q2 		$1.55M Hold
10,830
– – 1.05% 23
2024
Q1 		$1.39M Hold
10,830
– – 0.81% 33
2023
Q4 		$1.12M Hold
10,830
– – 0.81% 33
2023
Q3 		$985K Hold
10,830
– – 0.74% 37
2023
Q2 		$876K Hold
10,830
– – 0.63% 40
2023
Q1 		$862K Sell
10,830
-270
-2% -$19.1K 0.64% 41
2022
Q4 		$751K Hold
11,100
– – 0.57% 49
2022
Q3 		$553K Hold
11,100
– – 0.49% 61
2022
Q2 		$618K Sell
11,100
-600
-5% -$33.3K 0.49% 57
2022
Q1 		$650K Hold
11,700
– – 0.44% 68
2021
Q4 		$655K Sell
11,700
-250
-2% -$13.5K 0.43% 66
2021
Q3 		$574K Sell
11,950
-100
-0.8% -$4.83K 0.56% 61
2021
Q2 		$505K Hold
12,050
– – 0.47% 72
2021
Q1 		$406K Hold
12,050
– – 0.32% 95
2020
Q4 		$421K Hold
12,050
– – 0.32% 84
2020
Q3 		$418K Sell
12,050
-1,808
-13% -$60.3K 0.4% 74
2020
Q2 		$454K Buy
13,858
+1,638
+13% +$52.3K 0.49% 70
2020
Q1 		$368K Hold
12,220
– – 0.45% 70
2019
Q4 		$354K Buy
+12,220
New +$338K 0.26% 97

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Aberdeen Wealth Management's NVO Position: Q2 2026 in Review

Aberdeen Wealth Management opened a new position in Novo Nordisk (NVO) in Q2 2026: 4,946 shares worth $237K. The stake represents 0.11% of the portfolio and ranks #112 among its holdings. This is a return to the name: Aberdeen Wealth Management previously reported a position in NVO as recently as Q1 2025.

Aberdeen Wealth Management first reported a position in NVO in Q4 2019 and has held it in 23 quarters since. The position peaked at $1.55M in Q2 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Aberdeen Wealth Management held 4,946 shares of Novo Nordisk worth $237K as of Q2 2026.
  • Novo Nordisk was a new Aberdeen Wealth Management position in Q2 2026.
  • Novo Nordisk made up 0.11% of Aberdeen Wealth Management's portfolio in Q2 2026, its #112 holding.
  • Aberdeen Wealth Management first reported a position in Novo Nordisk in Q4 2019 and has held it in 23 quarters since.
  • Aberdeen Wealth Management's Novo Nordisk position peaked at $1.55M in Q2 2024.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Aberdeen Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.